151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old

類似資料

• 1436. Risk Factors for Invasive Pneumococcal Disease in Adults ≥65 Years Old Following Pneumococcal Conjugate Vaccine Recommendation
  著者:: Almendares, Olivia M, 等
  出版事項: (2018)
• 1470. Epidemiology of Invasive Pneumococcal Disease (IPD) Following 18 years of Pneumococcal Conjugate Vaccine (PCV) Use in the United States
  著者:: Pilishvili, Tamara, 等
  出版事項: (2020)
• Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years
  著者:: Black, Carla L., 等
  出版事項: (2017)
• Patient characteristics of Medicare beneficiaries who report not getting influenza and pneumococcal vaccinations, 2001–2013
  著者:: Shen, Angela K., 等
  出版事項: (2019)
• 180. Impact of Pneumococcal Conjugative Vaccine on Antibiotic Resistant Invasive Pneumococcal Disease in the United States
  著者:: Bajema, Kristina, 等
  出版事項: (2020)